SEC Form 4 · accession 0001193125-26-394388
BioStem Technologies, Inc. · BSEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael A Fortunato
Officer — Chief Accounting Officer
Period of report
Sep 15, 2026
Accepted (ET)
Sep 17, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001658678
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 15, 2026 | M | 4,234 | $0.00 | A | 68,664 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF6,F7 | — | Sep 15, 2026 | M | 4,234 | D | — | — | Common Stock | 4,234 | 16,941 | D |
| Options (Right to Buy)F1 | $1.07 | holding | — | — | — | — | Aug 16, 2027 | Common Stock | 200,000 | 200,000 | D |
| Options (Right to Buy)F2 | $2.99 | holding | — | — | — | — | Jan 4, 2033 | Common Stock | 100,000 | 100,000 | D |
| Options (Right to Buy)F3 | $15.11 | holding | — | — | — | — | May 9, 2035 | Common Stock | 11,582 | 11,582 | D |
| Options (Right to Buy)F4 | $15.11 | holding | — | — | — | — | Oct 13, 2035 | Common Stock | 2,340 | 2,340 | D |
| Options (Right to Buy)F5 | $5.50 | holding | — | — | — | — | Feb 11, 2036 | Common Stock | 38,546 | 38,546 | D |
| Restricted Stock UnitsF6,F8 | — | holding | — | — | — | — | — | Common Stock | 6,790 | 6,790 | D |
| Restricted Stock UnitsF6,F9 | — | holding | — | — | — | — | — | Common Stock | 31,818 | 31,818 | D |
Explanation of responses
- F1These options are fully vested and exercisable.
- F2These options vest according to the following schedule: 25% vested on January 4, 2024, the one year anniversary of the grant date, with the remaining options vesting in equal monthly installments over the subsequent three year period.
- F3These options vest according to the following schedule: 33% vested on May 9, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F4These options vest according to the following schedule: 33%% will vest on October 13, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F5These options vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F6Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F7These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024).
- F8These restricted stock units vest according to the following schedule: 33% vested on May 9, 2026, the one-year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.
- F9These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.